Army sbir phase II A2-6136
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH16C0097
- Awardee
-
Inbios International Inc. UEI CNJNQ1GMSN55
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $891,868
Award facts
- Opportunity
-
- HQ003414R2ASB Solicitation number
- Contract value 100% obligated
- $891,867.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 20 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Seattle, WA 98104, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$107,696 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $501,435 | |
| Other Administrative Action | $0 | |
| Original award | $498,129 |
About this award
This is a federal contract award to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, awarded by the U.S. Army Medical Command (MEDCOM), is for a Small Business Innovation Research (SBIR) Phase II project, valued at $891,867.91. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the ultimate completion date is January 14, 2020.
Inbios International Inc. is a specialized manufacturer of immunodiagnostic devices for infectious diseases. This SBIR Phase II contract supports the company's research and development efforts to advance diagnostic capabilities, particularly for neglected tropical diseases and emerging infectious diseases. Inbios has also been a critical partner to various government agencies, including the Department of Health and Human Services, the Defense Logistics Agency, and the Centers for Disease Control and Prevention, in addressing the COVID-19 pandemic through the supply of rapid diagnostic tests and other medical technologies.
Quick answers
Who was awarded contract W81XWH16C0097?
W81XWH16C0097 was awarded to Inbios International Inc. by Medical Command (Department of the Army) on August 15, 2016.
How much is contract W81XWH16C0097 worth?
The government has obligated $891,868 on W81XWH16C0097.
Was contract W81XWH16C0097 competed?
The extent of competition for W81XWH16C0097 was full and open competition after exclusion of sources. The government received 20 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award